Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
Phase 4
Completed
- Conditions
- Atrial FibrillationCryoablation
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- Aspire Foundation
- Target Recruit Count
- 10
- Registration Number
- NCT02875730
- Locations
- 🇺🇸
Saint Luke's Health System, Kansas City, Missouri, United States
Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Aspire Foundation
- Target Recruit Count
- 500
- Registration Number
- NCT01373944
- Locations
- 🇺🇸
Saint Luke's Cardiovascular Imaging Center, Kansas City, Missouri, United States
🇺🇸Saint Luke's North Cardiovascular Imaging Center, Kansas City, Missouri, United States
🇺🇸Saint Luke's East Cardiovascular Imaging Center, Lee's Summit, Missouri, United States
Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- Aspire Foundation
- Target Recruit Count
- 330
- Registration Number
- NCT00976053
- Locations
- 🇺🇸
Saint Luke's Cardiovascular Consultants, Kansas City, Missouri, United States
News
No news found